ClinicalTrialsFinder

First-line Treatment Failure Nasopharyngeal Carcinoma Clinical Trials in Guangdong

1 recruitingGuangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial

Nasopharyngeal Carcinoma (NPC)First-line Treatment Failure Nasopharyngeal Carcinoma
Sun Yat-sen University41 enrolled1 locationNCT07101744